Listen "Consensus Conversations: Neurotrophic Keratitis: Maintenance Therapy and Investigative Agents"
Episode Synopsis
Drs. Donaldson and Starr delve into cenegermin’s clinical trial data and whether or not it should be used in patients with stage 1 neurotrophic keratitis (NK). They also discuss a handful of investigational agents for treating NK.
This activity is supported by an unrestricted educational grant from Dompé.
Click here to view the webinar event, which includes images from the talk.
Check out the central hub of this webinar series.
Want to register with Evolve Medical Education? Click here.
This activity is supported by an unrestricted educational grant from Dompé.
Click here to view the webinar event, which includes images from the talk.
Check out the central hub of this webinar series.
Want to register with Evolve Medical Education? Click here.
More episodes of the podcast Let’s Talk Ophthalmology: an Evolve Medical Education Podcast
Adapting to Progress: Gene Therapy for nAMD
15/08/2024
Diabetic Macular Edema
08/03/2024
Managing AMD: Integrating Newer Therapies
08/03/2024
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.